We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
AUM
$3.52B
AUM Growth
+$274M
Cap. Flow
-$6.49M
Cap. Flow %
-0.18%
Top 10 Hldgs %
14.46%
Holding
5,080
New
686
Increased
1,775
Reduced
1,198
Closed
507

Sector Composition

Rank Sector Weight
1 Technology 11.78%
2 Financials 4.78%
3 Consumer Discretionary 3.56%
4 Industrials 3.41%
5 Healthcare 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGTX icon
4726
MeiraGTx Holdings
MGTX
$1.09B
$105 ﹤0.01%
16
+4
+33% +$24
PHAT icon
4727
Phathom Pharmaceuticals
PHAT
$912M
$105 ﹤0.01%
11
+9
+450% +$50
VTYX
4728
DELISTED
Ventyx Biosciences
VTYX
$105 ﹤0.01%
49
+42
+600% +$68
CRDF icon
4729
Cardiff Oncology
CRDF
$64.3M
0
OSUR icon
4730
OraSure Technologies
OSUR
$273M
0
SMID icon
4731
Smith-Midland
SMID
$161M
-1
Closed -$30
ULH icon
4732
Universal Logistics Holdings
ULH
$416M
0
BTMD icon
4733
Biote Corp
BTMD
$69.2M
-1
Closed -$4
LUCK
4734
Lucky Strike Entertainment
LUCK
$938M
$100 ﹤0.01%
+11
New +$99
NXXT
4735
NextNRG Inc
NXXT
$50.7M
$100 ﹤0.01%
+36
New +$110
NTIC icon
4736
Northern Technologies International Corp
NTIC
$76.4M
0
FATE icon
4737
Fate Therapeutics
FATE
$281M
$96 ﹤0.01%
+85
New +$99
STRS icon
4738
Stratus Properties
STRS
$158M
0
XFOR icon
4739
X4 Pharmaceuticals
XFOR
$363M
0
RCKY icon
4740
Rocky Brands
RCKY
$304M
0
RGCO icon
4741
RGC Resources
RGCO
$229M
0
STKS icon
4742
The ONE Group
STKS
$57.1M
0
BWMN icon
4743
Bowman Consulting
BWMN
$454M
$87 ﹤0.01%
+3
New +$74
CMDB
4744
Costamare Bulkers Holdings
CMDB
$457M
0
NWPX icon
4745
NWPX Infrastructure Inc
NWPX
$1.25B
0
CARM
4746
DELISTED
Carisma Therapeutics
CARM
$81 ﹤0.01%
206
LLYVK icon
4747
Liberty Live Group Series C
LLYVK
$9.11B
$81 ﹤0.01%
1
SHCO
4748
DELISTED
Soho House & Co
SHCO
$81 ﹤0.01%
+11
New +$68
ADCT icon
4749
ADC Therapeutics
ADCT
$146M
$80 ﹤0.01%
+30
New +$63
LYRA
4750
DELISTED
LYRA THERAPEUTICS INC
LYRA
$80 ﹤0.01%
+306
New +$2.54K

Similar funds

IFP Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, IFP Advisors held 5,080 positions worth $3.52B, up 8.4% from $3.24B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

IFP Advisors's Q2 2025 filing shows 686 new, 1,775 increased, 1,198 reduced and 507 closed positions. Its largest new stake was Innovator US Equity Ultra Buffer ETF February: 98,680 shares worth $3.39M. The largest sale was Invesco QQQ Trust, an estimated $19.9M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • IFP Advisors's largest Q2 2025 buy was Innovator US Equity Ultra Buffer ETF February: 98,680 shares worth $3.39M.
  • IFP Advisors added most to iShares S&P 500 Growth ETF in Q2 2025, an estimated $20.2M increase.
  • IFP Advisors's biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $19.9M.
  • IFP Advisors fully exited Vanguard Long-Term Corporate Bond ETF in Q2 2025, selling an estimated $1.97M.
  • IFP Advisors's ten largest holdings make up 14% of its $3.52B portfolio in Q2 2025.
  • IFP Advisors opened 686 new positions and closed 507 in Q2 2025.
  • IFP Advisors's portfolio value rose 8.4% quarter-over-quarter to $3.52B.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.